|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0016018,
umls-concept:C0027051,
umls-concept:C0031809,
umls-concept:C0034656,
umls-concept:C0035173,
umls-concept:C0040044,
umls-concept:C0205087,
umls-concept:C1274040,
umls-concept:C1280500,
umls-concept:C1442770,
umls-concept:C1515980,
umls-concept:C1521801,
umls-concept:C1623258
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1994-8-26
|
|
pubmed:abstractText |
Thrombolytic therapy reduces mortality after acute myocardial infarction, even when treatment is initiated relatively late after onset of symptoms. The mechanism underlying this survival benefit is incompletely understood.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
90
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
746-52
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8044943-Double-Blind Method,
pubmed-meshheading:8044943-Electrocardiography,
pubmed-meshheading:8044943-Female,
pubmed-meshheading:8044943-Humans,
pubmed-meshheading:8044943-Male,
pubmed-meshheading:8044943-Middle Aged,
pubmed-meshheading:8044943-Myocardial Infarction,
pubmed-meshheading:8044943-Prospective Studies,
pubmed-meshheading:8044943-Recombinant Proteins,
pubmed-meshheading:8044943-Risk Factors,
pubmed-meshheading:8044943-Signal Processing, Computer-Assisted,
pubmed-meshheading:8044943-Tachycardia, Ventricular,
pubmed-meshheading:8044943-Thrombolytic Therapy,
pubmed-meshheading:8044943-Time Factors,
pubmed-meshheading:8044943-Tissue Plasminogen Activator
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy.
|
|
pubmed:affiliation |
Division of Cardiology, St Luke's-Roosevelt Hospital Center, New York, NY 10025.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
